S. Asia and ?. , 13 c [?0

G. Report, UNAIDS report on the global AIDS epidemic 2013, Geneva: UNAIDS, 2013.

. Drugs@fda, FDA approved drug products

K. Chokephaibulkit, N. Plipat, T. Cressey, K. Frederix, W. Phongsamart et al., Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine, AIDS, vol.19, issue.14, pp.1495-1504, 2005.
DOI : 10.1097/01.aids.0000183625.97170.59

O. Brien, D. Sauvageot, D. Zachariah, R. Humblet, and P. , In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy, AIDS, vol.20, pp.1955-60, 2006.

U. Paediatric and H. Aids, Create the market for child-friendly HIV medicines

B. Waning, E. Diedrichsen, E. Jambert, T. Bärnighausen, Y. Li et al., The global paediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of paediatric formulations and HIV/AIDS treatment in children. BMC Paediatrics. [serial online, Available from: URL: http://www. biomedcentral.com, pp.741471-2431, 2010.

R. Maronna and V. Yohai, Robust regression with both continuous and categorical predictors, Journal of Statistical Planning and Inference, vol.89, issue.1-2, pp.197-214, 2000.
DOI : 10.1016/S0378-3758(99)00208-6

. Pharma-times-online, Breakthrough deal signed for paediatric HIV drugs [Online], 2006.

. World-trade and . Organization, Least-developed country members -obligations under Article 70.9 of the TRIPS Agreement with Respect to Pharmaceutical Products, 2014.

S. Moon, E. Jambert, M. Childs, V. Schoen-angerer, and T. , A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries, Globalization and Health, vol.7, issue.1, p.39, 2011.
DOI : 10.2174/1874613601004020037

P. Yadav, Differential pricing for pharmaceuticals: review of current knowledge, new findings and ideas for action. A study conducted for the UK Department for International Development (DFID) Zaragoza: MIT-Zaragoza International Logistics Program Available from: URL: https://www.gov.uk/government, 2010.

P. Danzon and A. Towse, Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents, SSRN Electronic Journal, vol.3, issue.3, pp.183-205, 2003.
DOI : 10.2139/ssrn.422821

C. Perez, C. Mace, D. Berman, and J. Double, Accessing ARVs: untangling the web of price reductions for developing countries, p.2013, 2001.

L. Hawkins, . Who, and . Hai, Project on medicines prices and availability: review series on Pharmaceutical pricing policies and interventions. Work paper 4: competition policy. World Health Organisation and Health Action International World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings, Geneva, 2004.

J. Perriens, V. Habiyambere, B. Dongmo-nguimfack, and G. Hirnschall, Prices paid for adult and paediatric antriretroviral treatment by low-and middle-income countries in 2012: high, low or just right? Antivir Ther, pp.39-47, 2014.

V. Habiyambere, Who Survey on ARV and diagnostic use 2012 Preliminary results Available from http, 2015.